Growth Investing Explained

Growth investing means buying companies expanding revenue, earnings, and market share rapidly, with the expectation that today's premium valuation will be justified by tomorrow's much larger business. It's the strategy that captures the largest absolute returns when it works, the strategy responsible for the biggest fortunes built in modern markets, and also the strategy most likely to produce devastating losses when growth disappoints.

What it measures

Growth investing focuses on metrics that signal business expansion:

• Revenue growth: 20%+ annually for true growth stocks. Often 30-50%+ for hyper-growth.
• Earnings growth: Even faster than revenue growth, indicating operating leverage.
• Market share gains: Expanding share within addressable markets.
• TAM expansion: New use cases, geographies, or categories opening.
• Reinvestment runway: Ability to deploy capital at high returns for years.

Growth investors typically pay premium multiples (P/E ratios of 30-100+, EV/Sales of 10-30+) on the thesis that current earnings dramatically understate future earning power. The math works when growth compounds for long periods at high rates without significant deceleration.

The two main schools of growth investing:

Quality growth: Focuses on businesses with sustainable competitive advantages, strong unit economics, and long runways. Willing to pay premium multiples for proven compounders. The Buffett-Munger evolution toward businesses like $AAPL.

Aggressive growth: Focuses on hyper-growth businesses regardless of current profitability. Targets disruptive technologies and emerging categories. Often willing to own pre-profit businesses with strong revenue trajectories. The Cathie Wood / ARK style.

Both can work; both can fail spectacularly when underlying assumptions don't materialize.

How to use it in practice

Growth investing has produced extraordinary returns historically when applied to the right companies at the right time:

$AMZN compounded at over 25% annually for two decades despite trading at 100+ P/E ratios for most of that period. Investors who held through the dot-com crash, multiple corrections, and persistent skepticism about profitability earned among the best returns in market history.

$NVDA grew from a niche graphics chip company to the most valuable AI infrastructure provider, with revenue growing from $5B to $130B+ in a decade. The stock returned over 100x for early holders.

$META grew from social network to global advertising platform with 4 billion users. Despite multiple drawdowns (2018, 2022), long-term holders have compounded wealth dramatically.

The 2022 growth selloff was the recent stress test. As Fed rates rose, long-duration growth stocks faced severe multiple compression. The Russell 1000 Growth Index declined nearly 30% in 2022, with many high-multiple names declining 50-70%. Many high-flyers from the 2020-2021 era never recovered, including SaaS stocks, EV plays, and unprofitable tech.

The 2023-2025 recovery in growth was led by the "Magnificent Seven" (Nvidia, Microsoft, Apple, Google, Amazon, Meta, Tesla), which collectively drove most of the S&P 500's returns. The concentration of returns in mega-cap quality growth has been historically unusual.

Several frameworks for growth investing:

The growth investor's checklist:

• Is the company growing revenue 20%+ annually?
• Is growth driven by sustainable factors (TAM expansion, secular trends)?
• Is the business achieving operating leverage as it scales?
• Are unit economics improving over time?
• Is competitive position strengthening or weakening?
• What's the realistic addressable market over 10 years?

Stage-based valuation framing:

• Early stage: Revenue growth + market opportunity matters most. Profitability secondary.
• Mid stage: Revenue growth + path to profitability + unit economics critical.
• Mature growth: Revenue + earnings growth + free cash flow generation all matter.

The PEG ratio (P/E divided by growth rate) provides one framework for whether growth multiples are justified. PEG below 1.0 suggests reasonable price for the growth; above 2.0 suggests paying excessive premium.

The biggest risks in growth investing:

Growth deceleration: When a 40% grower decelerates to 20%, the multiple compression alone can produce 50%+ losses even before any earnings disappointment.

Unit economics failures: Many growth stories that seem to work actually have poor unit economics that only become apparent at scale.

Competition: Growth attracts competition. Many "winner-take-all" markets actually have multiple competitors splitting the prize.

Technology disruption: The companies disrupting today are themselves vulnerable to disruption tomorrow. Yesterday's growth stocks (taxi cab companies, traditional media) became today's value traps.

For implementation, growth investing requires:

• Position sizing discipline: Concentrated bets on growth stocks can produce both extraordinary returns and devastating losses. Sizing matters enormously.
• Patience for compounding: Many great growth stocks have multi-year periods of mediocre performance even within long-term uptrends.
• Discipline to sell when thesis breaks: Growth investors often struggle to sell when a company's growth dramatically decelerates. The willingness to recognize when the thesis has changed is critical.

Common mistakes

Paying any price for growth. No matter how attractive the business, valuation matters. The dot-com bust and 2022 growth selloff both reminded investors that even great businesses become bad investments at extreme multiples.

Extrapolating peak growth rates. A company growing 80% one year almost never sustains that rate. Mathematical base effects guarantee deceleration. Modeling forward should always discount peak rates.

Ignoring profitability progression. Revenue growth without margin progression eventually fails. Companies that promise eventual profitability for decades without delivering it often disappoint catastrophically.

Concentration without conviction. Many investors put 10-20% of net worth in single growth stocks based on enthusiasm rather than deep analysis. The asymmetric risk profile of high-multiple growth stocks makes concentration particularly dangerous.

ACCE perspective

Growth is a 25% component of our overall scoring system. We weight revenue growth YoY at 50%, earnings growth at 30%, and sequential revenue growth at 20% within the growth score.

We track growth alongside quality and value because pure growth investing has historically produced too much risk for typical retail investors. Quality-growth combinations (high growth with strong returns on capital and reasonable valuations) tend to produce better risk-adjusted returns than pure growth screens.

For investors who want growth-tilted exposure, the most reliable framework is buying quality growth at reasonable multiples rather than chasing the highest-growth names. The "growth at a reasonable price" approach (GARP) tends to outperform both deep value and pure growth strategies over full market cycles.